Dr. Felipe Zilly
Counsel/Patent Attorney Intellectual Property
Languages
English, German, Spanish
-
Overview
-
Experience
-
Credentials
-
Insights and events
Felipe Zilly is a fully qualified German and European Patent Attorney who advises German and international clients on patent infringement and validity proceedings and is a senior member of our global patent litigation team. With most of his matters having a multi-jurisdictional or cross-border angle and involving coordination within international teams, he is uniquely qualified to represent clients before the newly established Unified Patent Court.
Having obtained his doctorate in biochemistry, he focuses on proceedings in the fields of biotechnology, chemistry, life sciences, medical devices, pharmaceuticals, and production processes. In addition, he has experience in matters relating to mechanics and telecommunications. His particular interest is in pharmaceutical processes and the interface of IP and regulatory protection of pharmaceutical products.
Many of his clients request legal advice on technical property rights, commission freedom-to-operate analyses and legal opinions as part of due diligence in M&A projects.
His clients appreciate the way he leverages his research experience obtained working on molecular neuroscience at the Max Planck Institute for Biophysical Chemistry and on directed enzyme evolution for organic synthesis at the Max Planck Institute for Coal Research.
Prior to joining Hogan Lovells, Felipe worked as an in-house patent attorney for a large multinational consumer goods group headquartered in Dusseldorf. He was responsible for all patent matters in connection with specific consumer products, their production processes, and related IoT devices.
Representative experience
Assisting over several years a world leading pharmaceutical company with the enforcement and defence of a fundamental patent regarding the first approved antibody cancer treatment.
Assisting in the development of a European patent enforcement strategy for a world leading pharmaceutical company against biosimilar manufacturers.
Representing a global manufacturer of heart valve implants in multiple opposition, cancellation and infringement proceedings (incl. PI proceedings); international coordination of proceedings.
Advising a biotech company in making its most valuable patents “ready for litigation”.
Assisting a US biotech company in the development of a European patent enforcement strategy against biosimilar manufacturers.
Credentials
- Business Chemist (MSc equiv.), University of Hagen, 2015
- Doctor of natural sciences, University of Göttingen/Max Planck Institute for Biophysical Chemistry, 2006
- Biochemist (MSc equiv.), Ruhr-Universität Bochum, 2002
- Chamber of Patent Attorneys
- European Institute of Representatives before the European Patent Office
- Fédération Internationale des Conseils en Propriété Industrielle
- DECHEMA
- VAA
- European Patent Litigators Association (EPLIT)